Weight reduction improves markers of hepatic function and insulin resistance in type-2 diabetic patients with non-alcoholic fatty liver

African Health Sciences

Volumn 13, Issue 3, 2013, Pages 667-672

  Al Jiffri, O ^a   Al Sharif, F M ^a   Abd El Kader, Shehab M ^a   Ashmawy, E M ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Insulin resistance; Markers of hepatic function; Non alcoholic fatty liver; Type 2 diabetes; Weight reduction

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AEROBIC EXERCISE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTHROPOMETRIC PARAMETERS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CONTROLLED STUDY; EXERCISE INTENSITY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT INSULIN RESISTANCE INDEX; HUMAN; INSULIN RESISTANCE; LIVER FUNCTION; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; WEIGHT REDUCTION;

INSULIN RESISTANCE; MARKERS OF HEPATIC FUNCTION; NON-ALCOHOLIC FATTY LIVER; TYPE-2 DIABETES; WEIGHT REDUCTION;

ADULT; ANTHROPOMETRY; BIOLOGICAL MARKERS; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DIET, REDUCING; EXERCISE; FATTY LIVER; HUMANS; INSULIN RESISTANCE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; TRANSAMINASES; WEIGHT LOSS;

EID: 84883664631     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: 10.4314/ahs.v13i3.21     Document Type: Article

References (26)

1. Fan J, Farrell G. Epidemiology of nonalcoholic fatty liver disease in China. J Hepatol 2009; 50: 204-210.
2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231.
3. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 2010; 51: 679-689.
4. Marchesini G, Bugianesi E, Forlani G. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-923.
5. Ito O, Muroya Y, Mori N, Nagasaka M, Kanazawa M, Kohzuki M. Poster 232: Improvement of Pediatric Nonalcoholic Fatty Liver Disease by Diet and Physical Exercise: A Case Report. Arch Phys Med Rehabil 2007; 88 (9): E76
6. Targher G, Bellis A, Fornengo P, Ciaravella F, Pichiri I, Perin P, etal. Prevention and treatment of nonalcoholic fatty liver disease. Dig Liver Dis 2010; 42(5): 331-340.
7. Andersen T, Gluud C, Franzmann M, Christoffersen P. Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol 1991; 12: 224-229.
8. Wang R, Koretz R, Yee H. Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review. Am J Med 2003; 115: 554-559.
9. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008;31(Suppl. 1):S55-60.
10. Wilund KR. Is the anti-inflammatory effect of regular exercise responsible for reduced cardiovascular disease? Clin Sci (Lond) 2007; 112(11):543-55.
11. Saris W, Blair S, van Baak M. How much physical activity is enough to prevent unhealthy weight gain? Outcome of the IASO 1st Stock Conference and consensus statement. Obes Rev 2003; 4:101-114.
12. Cox K, Burke V, Morton A. Independent and additive effects of energy restriction and exercise on glucose and insulin concentrations in sedentary overweight men. Am J Clin Nutr 2004; 80: 308-316.
13. Kantartzis K, Thamer C, Peter A. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease. Gut 2009; 58: 1281-1288.
14. St George A, Bauman A, Johnston A. Independent effects of physical activity in patients with nonalcoholic fatty liver disease. Hepatology 2009; 50: 68-76.
15. Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S, etal. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. Journal of Hepatology. 1997; 27, (1):103-107.
16. Chen S, Liu C, Li S, Huang H, Tsai C, Jou H. Effects of Therapeutic Lifestyle Program on Ultrasound-diagnosed Nonalcoholic Fatty Liver Disease. Journal of the Chinese Medical Association 2008; 71(11):551-558.
17. Tilg H, Kaser A. Treatment strategies in nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2005; 2:148-155.
18. Suzuki A, Lindor K, St Saver J, Lymp J, Mendes F, Muto A, Okada T, Angulo P. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. Journal of Hepatology 2005; 43(6):1060-1066
19. Hickman I, Jonsson J, Prins J. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut 2004; 53: 413-419.
20. Petersen K, Dufour S, Befroy D. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 2005; 54: 603-608.
21. Perseghin G, Price T, Petersen K, Roden M, Cline G, Gerow K. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med 1996; 335: 1357-1362.
22. Ross R, Dagnone D, Jones P, Smith H, Paddags A, Hudson R. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized controlled trial. Ann Intern Med 2000; 133: 92-103.
23. Di Buono, M, Hannah JS, Katzel LL, Jones PJ. Weight loss due to energy restriction suppresses cholesterol biosynthesis in overweight, mildly hypercholesterolemic men. J. Nutr 1999; 129 (8): 1545-8.
24. Lamarche B, Despress J, Pouliot MC, Moorjani S, Lupien P, Jheriault G, Tremblay A, Nadeau A, Bouchard C. Is body fat loss a determinant factor in the improvement of carbohydrate and lipid metabolism following aerobic exercise training in obese women?. Metabolism 1992; 41 (11): 1249-1256.
25. Browning J, Davis J, Saboorian M. A lowcarbohydrate diet rapidly and dramatically reduces intrahepatic triglyceride content. Hepatology 2006; 44: 487-488.
26. Weaterbacka J, Lammi K, Hakkinen A. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab 2005; 90:2804-2809.